TriMas/$TRS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About TriMas
TriMas Corp designs, develops and manufactures a diverse set of products for the consumer products, and industrial markets . The company operates through two segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners. The packaging segment generates majority of its revenue.
- Ticker
- $TRS
- Sector
- Materials
- Primary listing
- NASDAQ
- Employees
- 3,700
- Headquarters
- Bloomfield Hills, United States
- Website
- trimas.com
TriMas Metrics
BasicAdvanced
$1.4B
1.58
$24.18
0.61
$0.16
0.42%
Price and volume
Market cap
$1.4B
Beta
0.61
52-week high
$45.43
52-week low
$30.43
Average daily volume
338K
Dividend rate
$0.16
Financial strength
Current ratio
8.036
Quick ratio
7.211
Long term debt to equity
0.295
Total debt to equity
0.301
Dividend payout ratio (TTM)
0.66%
Interest coverage (TTM)
1.87%
Profitability
EBITDA (TTM)
63.13
Gross margin (TTM)
20.91%
Net profit margin (TTM)
135.18%
Operating margin (TTM)
5.01%
Effective tax rate (TTM)
-61.82%
Revenue per employee (TTM)
$180,000
Management effectiveness
Return on assets (TTM)
1.18%
Return on equity (TTM)
9.36%
Valuation
Price to earnings (TTM)
1.578
Price to revenue (TTM)
2.094
Price to book
0.94
Price to tangible book (TTM)
1.26
Price to free cash flow (TTM)
-15.528
Free cash flow yield (TTM)
-6.44%
Free cash flow per share (TTM)
-2.456
Dividend yield (TTM)
0.42%
Forward dividend yield
0.42%
Growth
Revenue change (TTM)
28.40%
Earnings per share change (TTM)
2,127.75%
3-year revenue growth (CAGR)
-8.62%
10-year revenue growth (CAGR)
-1.67%
3-year earnings per share growth (CAGR)
169.72%
10-year earnings per share growth (CAGR)
41.84%
What the Analysts think about TriMas
Analyst ratings (Buy, Hold, Sell) for TriMas stock.
Analyst projections of the future price of TriMas stock.
Bulls say / Bears say
TriMas raised its 2026 adjusted EPS outlook to $1.60–$1.70 and still expects 3%–6% sales growth and more than 300 basis points of adjusted margin improvement. Q2 adjusted operating profit rose 29.1%, supporting the case that cost reductions and operational improvements are lifting profitability. (TriMas)
Specialty Products sales rose 10.2% in Q2, and TriMas raised its full-year sales growth outlook for the segment to 6%–9%, citing strong orders and market-share gains at Norris Cylinder. If the company resolves the current production bottlenecks, that demand could translate into stronger earnings. (TriMas)
The Aerospace sale generated about $1.2 billion in after-tax proceeds, giving TriMas room to repay borrowings, buy back shares and fund growth in packaging and life sciences. The company said it had repurchased more than five million shares since announcing the sale while retaining flexibility for further investment. (TriMas)
Packaging sales were essentially flat in Q2 as growth in industrial and life sciences was offset by lower beauty and personal care, and food and beverage sales. Weakness across these important customer markets could make the company’s 3%–6% full-year growth target harder to achieve. (TriMas)
Specialty Products’ Q2 operating margin fell to 2.2% from 4.4% a year earlier, as higher raw-material costs, temporary labour, overtime and production inefficiencies outweighed sales growth. This shows that stronger orders may not deliver much profit until staffing and throughput improve. (TriMas)
The raised 2026 EPS outlook assumes $9–$10 million of interest income in each remaining quarter and no significant change in interest rates or redeployment of the cash proceeds. Earnings could be less supportive if rates fall or TriMas puts that cash to work in lower-yielding investments or acquisitions. (TriMas)
Data summarised monthly by Lightyear AI. Last updated on 5 Oct 2026.
TriMas Financial Performance
Revenues and expenses
TriMas Earnings Performance
Company profitability
Upcoming events
TriMas News
AllArticlesVideos
Funds containing TriMas
AllUSDEURGBP
Fund name | Fund size | $TRS weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.04% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.04% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.01% |
iShares MSCI World Small Cap£WLDS | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | $9B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.